It is noteworthy that our large study offered similar sample size to assess genetic association with early AMD to a number of previous GWAS that assessed the associations with late AMD [10], [11], [13], [14], [15], but in contrast to other studies, we detected no significant variants besides CFH and ARMS2 variants at genome-wide significance. This evidence concerns the gene ARMS2 and age-related macular degeneration.